Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype

Molecular and Cellular Biology

Volumn 23, Issue 16, 2003, Pages 5947-5957

  Maxwell, Megan ^a   Bjorkman, Jonas ^a   Nguyen, Taro ^a   Sharp, Peter ^b   Finnie, John ^c   Paterson, Carol ^d   Tonks, Ian ^d   Paton, Barbara C ^b,e   Kay, Graham F ^d   Crane, Denis I ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; MEMBRANE PROTEIN; PLASMALOGEN; RECOMBINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; BRAIN CORTEX; CELL MIGRATION; CHEMICAL ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FAILURE TO THRIVE; FATTY ACID OXIDATION; GENE; GENE DISRUPTION; GENE INACTIVATION; GENE MUTATION; GENETIC CODE; INTRAUTERINE GROWTH RETARDATION; MOUSE; MUSCLE HYPOTONIA; NERVE CELL; NEWBORN DEATH; NONHUMAN; PATHOGENESIS; PEROXISOME; PEX13 GENE; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN TRANSPORT; SKIN FIBROBLAST; TISSUE CULTURE; ZELLWEGER SYNDROME;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL MOVEMENT; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; INTEGRASES; LIVER; LUMINESCENT PROTEINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; MUTATION; NEURONS; PEROXISOMES; PHENOTYPE; PLASMIDS; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; ZELLWEGER SYNDROME;

ANIMALIA; MUS MUSCULUS;

EID: 0042632799     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.16.5947-5957.2003     Document Type: Article

References (42)

1. Baes, M., P. Gressens, E. Baumgart, P. Carmeliet, M. Casteels, M. Fransen, P. Evrard, D. Fahimi, P. E. Declercq, D. Collen, P. P. van Veldhoven, and G. P. Mannaerts. 1997. A mouse model for Zellweger syndrome. Nat. Genet. 17:49-57.
2. Baumgart, E., I. Vanhorebeek, M. Grabenbauer, M. Borgers, P. E. Declereq, H. D. Fahimi, and M. Baes. 2001. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am. J. Pathol. 159:1477-1494.
3. Bjorkman, J., S. J. Gould, and D. I. Crane. 2002. Pex13, the mouse ortholog of the human peroxisome biogenesis disorder PEX13 gene: gene structure, tissue expression, and localization of the protein to peroxisomes. Genomics 79:162-168.
4. Bjorkman, J., I. Tonks, M. A. Maxwell, C. Paterson, G. F. Kay, and D. I. Crane. 2002. Conditional inactivation of the peroxisome biogenesis Pex13 gene by Cre-loxP excision. Genesis 32:179-180.
5. Chen, N., and D. I. Crane. 1992. Induction of the major integral membrane protein of mouse liver peroxisomes by peroxisome proliferators. Biochem. J. 283:605-610.
6. Crane, D. I., A. C. Hemsley, and C. J. Masters. 1985. Purification of peroxisomes from livers of normal and clofibrate-treated mice. Anal. Biochem. 148:436-445.
7. Dammai, V., and S. Subramani. 2001. The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol. Cell 105:187-196.
8. Distel, B., R. Erdmann, S. J. Gould, G. Blobel, D. I. Crane, J. M. Cregg, G. Dodt, Y. Fujiki, J. M. Goodman, W. W. Just, J. A. Kiel, W. H. Kunau, P. B. Lazarow, G. P. Mannaerts, H. W. Moser, T. Osumi, R. A. Rachubinski, A. Roscher, S. Subramani, H. F. Tabak, T. Tsukamoto, D. Valle, I. van der Klei, P. P. van Veldhoven, and M. Veenhuis. 1996. A unified nomenclature for peroxisome biogenesis factors. J. Cell Biol. 135:1-3.
9. Elgersma, Y., L. Kwast, A. Klein, T. Voorn-Brouwer, M. van den Berg, B. Metzig, T. America, H. F. Tabak, and B. Distel. 1996. The SH3 domain of the Saccharomyces cerevisiae peroxisomal membrane protein Pex13p functions as a docking site for Pex5p, a mobile receptor for the import PTS1-containing proteins. J. Cell Biol. 135:97-109.
10. Erdmann, R., and G. Blobel. 1996. Identification of Pex13p, a peroxisomal membrane receptor for the PTS1 recognition factor. J. Cell Biol. 135:111-121.
11. Fahimi, H. D. 1979. An assessment of the DAB methods for cytochemical detection of catalase and peroxidase. J. Histochem. Cytochem. 27:1365-1366.
12. Faust, P. L., and M. E. Hatten. 1997. Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J. Cell Biol. 139:1293-1305.
13. Faust, P. L., H. M. Su, A. Moser, and H. W. Moser. 2001. The peroxisome deficient PEX2 Zellweger mouse: pathologic and biochemical correlates of lipid dysfunction. J. Mol. Neurosci. 16:289-297.
14. Goldfischer, S., C. L. Moore, A. B. Johnson, A. J. Spiro, M. P. Valsamis, H. K. Wisniewski, R. H., Ritch, W. T. Norton, I. Rapin, and L. M. Gartner. 1973. Peroxisomal and mitochondrial defects in the cerebro-hepato- renal syndrome. Science 182:62-64.
15. Gould, S. J., J. E. Kalish, J. C. Morrell, J. Bjorkman, A. J. Urquhart, and D. I. Crane. 1996. Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTS1 receptor. J. Cell Biol. 135:85-95.
16. Gould, S. J., and D. Valle. 2000. Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet. 16:340-345.
17. Gould, S. J., D. Valle, and G. V. Raymond. 2001. The peroxisome biogenesis disorders, p. 3181-3217. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The metabolic and molecular bases of inherited disease, 8th ed., vol. 2. McGraw-Hill, New York, N.Y.
18. Gressens, P., M. Baes, P. Leroux, A. Lombet, P. Van Veldhoven, A. Janssen, J. Vamecq, S. Marret, and P. Evrard. 2000. Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction. Ann. Neurol. 48:336-343.
19. Hughes, J. L., D. I. Crane, E. Robertson, and A. Poulos. 1993. Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders. Virchows Arch. A Pathol. Anat. 423:459-468.
20. Hughes, J. L., A. Poulos, D. I. Crane, C. W. Chow, L. J. Sheffield, and D. Sillence. 1992. Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata. Eur. J. Pediatr. 151:829-836.
21. Kwan, K.-M. 2002. Conditional alleles in mice: practical considerations for tissue specific knockouts. Genesis 32:49-62.
22. Li, X., E. Baumgart, J. C. Morrell, G. Jimenez-Sanchez, D. Valle, and S. J. Gould. 2002. PEX11β deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol. Cell. Biol. 22:4358-4365.
23. Liu, Y., J. Bjorkman, A. Urquhart, R. J. Wanders, D. I. Crane, and S. J. Gould. 1999. PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders. Am. J. Hum. Genet. 65:621-634.
24. Maxwell, M. A., T. Allen, P. Solley, T. Svingen, B. C. Paton, and D. I. Crane. 2002. Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients. Hum. Mut. 20:342-351.
25. Maxwell, M. A., P. V. Nelson, S. J. Chin, B. C. Paton, W. F. Carey, and D. I. Crane. 1999. A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype. Hum. Genet. 105:38-44.
26. Moser, H. W. 1996. Pathogenetic mechanisms in peroxisomal disorders. Curr. Opin. Neurol. 9:473-476.
27. Moser, H. W. 1993. Peroxisomal diseases. Adv. Hum. Genet. 21:1-106.
28. Moser, H. W. 1999. Peroxisomal disorders: classification and overview of biochemical abnormalities. Rev. Neurol. 28(Suppl. 1):S45-S48.
29. Nagy, A. 2000. Cre recombinase: the universal reagent for genome tailoring. Genesis 26:99-109.
30. Otera, H., T. Harano, M. Honsho, K. Ghaedi, S. Mukai, A. Tanaka, A. Kawai, N. Shimizu, and Y. Fujiki. 2000. The mammalian peroxin Pex5pL, the longer isoform of the mobile peroxisome targeting signal (PTS) type 1 transporter, translocates the Pex7p.PTS2 protein complex into peroxisomes via its initial docking site, Pex14p. J. Biol. Chem. 275:21703-21714.
31. Otera, H., K. Setoguchi, M. Hamasaki, T. Kumashiro, N. Shimizu, and Y. Fujiki. 2002. Peroxisomal targeting signal receptor Pex5p interacts with cargoes and import machinery components in a spatiotemporally differentiated manner: conserved Pex5p WXXXF/Y motifs are critical for matrix protein import. Mol. Cell. Biol. 22:1639-1655.
32. Paton, B. C., P. C. Sharp, D. I. Crane, and A. Poulos. 1996. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects. J. Clin. Investig. 97:681-688.
33. Poulos, A., R. Gibson, P. Sharp, K. Beckman, and P. Grattan-Smith. 1994. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Ann. Neurol. 36:741-746.
34. Poulos, A., L. Sheffield, P. Sharp, G. Sherwood, D. Johnson, K. Beckman, A. J. Fellenberg, J. E. Wraith, C. W. Chow, S. Usher, and H. Singh. 1988. Rhizomelic chondrodysplasia punctata: clinical, pathologic and biochemical findings in two patients. J. Pediatr. 113:685-690.
35. Purdue, P. E., and P. B. Lazarow. 2001. Peroxisome biogenesis. Annu. Rev. Cell Dev. Biol. 17:701-752.
36. Purdue, P. E., and P. B. Lazarow. 1996. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J. Cell Biol. 134:849-862.
37. Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:5080-5081.
38. Sheikh, F. G., K. Pahan, M. Khan, E. Barbosa, and I. Singh. 1998. Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Proc. Natl. Acad. Sci. USA 95:2961-2966.
39. Shimozawa, N., Y. Suzuki, Z. Zhang, A. Imamura, R. Toyama, S. Mukai, Y. Fujiki, T. Tsukamoto, T. Osumi, T. Orii, R. J. Wanders, and N. Kondo. 1999. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. Hum. Mol. Genet. 8:1077-1083.
40. Stein, K., A. Schell-Steven, R. Erdmann, and H. Rottensteiner. 2002. Interactions of Pex7p and Pex18p/Pex21p with the peroxisomal docking machinery: implications for the first steps in PTS2 protein import. Mol. Cell. Biol. 22:6056-6069.
41. Toyama, R., S. Mukai, A. Itagaki, S. Tamura, N. Shimozawa, Y. Suzuki, N. Kondo, R. J. Wanders, and Y. Fujiki. 1999. Isolation, characterization and mutation analysis of PEX13-defective Chinese hamster ovary cell mutants. Hum. Mol. Genet. 8:1673-1681.
42. Urquhart, A. J., D. Kennedy, S. J. Gould, and D. I. Crane. 2000. Interaction of Pex5p, the type 1 peroxisome targeting signal receptor, with the peroxisomal membrane proteins Pex14p and Pex13p. J. Biol. Chem. 275:4127-4136.